Breakthrough gene therapy jab reverses hearing loss in weeks
The cutting-edge therapy improved hearing in children and adults with congenital deafness or severe hearing impairment, with a 7-year-old regaining almost full hearing in a clinical trial, researchers from Sweden's Karolinska Institutet said.
The clinical trial, detailed in the journal Nature Medicine, showed that a healthy copy of the OTOF gene injected in the inner ear improved hearing of all 10 participants.
The small-scale trial included people who had a genetic form of deafness or severe hearing impairment caused by mutations in a gene called OTOF.
These mutations cause a deficiency of the protein otoferlin, which plays a key role in transmitting sound signals from the ear to the brain.
While the therapy seemed to work best in children, researchers said, it could benefit adults as well.
In the trial, a synthetic, harmless version of the adeno-associated virus was used to deliver a properly functional OTOF gene to the inner ear via a single injection.
The effects of the therapy were evident in the majority of patients, whose hearing recovered rapidly after just a month.
After six months, researchers noted considerable hearing improvement in all participants, with their average volume of perceptible sound improving from 106 decibels to 52.
Those between the ages of five and eight responded best to the treatment, the study found.
One seven-year-old girl quickly recovered almost all her hearing, and she was able to hold daily conversations with her mother four months afterwards.
'This is the first time that the method has been tested in teenagers and adults,' Maoli Duan, an author of the study from Karolinska Institutet, said.
"Hearing was greatly improved in many of the participants, which can have a profound effect on their life quality. We will now be following these patients to see how lasting the effect is.'
Researchers also found that the treatment was safe and well-tolerated. Participants did not report any serious adverse reactions in the follow-up period of 6-12 months.
The most common reaction was a reduction in the number of the immune system's neutrophils, a type of white blood cell.
"OTOF is just the beginning," Dr Duan said, adding that researchers were working on other common genes behind deafness such as GJB2 and TMC1.
'These are more complicated to treat, but animal studies have so far returned promising results. We are confident that patients with different kinds of genetic deafness will one day be able to receive treatment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Google DeepMind has grand ambitions to ‘cure all diseases' with AI. Now, it's gearing up for its first human trials
Alphabet's Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind's AlphaFold breakthrough, the company is pairing cutting-edge AI with pharma veterans to design medicines faster, cheaper, and more accurately. Alphabet's secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer, told Fortune. 'There are people sitting in our office in King's Cross, London, working, and collaborating with AI to design drugs for cancer,' Murdoch said during an interview in Paris. 'That's happening right now.' After years in development, Murdoch says human clinical trials for Isomorphic's AI-assisted drugs are finally in sight. 'The next big milestone is actually going out to clinical trials, starting to put these things into human beings,' he said. 'We're staffing up now. We're getting very close.' The company, which was spun out of DeepMind in 2021, was born from one of DeepMind's most celebrated breakthroughs, AlphaFold, an AI system capable of predicting protein structures with a high level of accuracy. Interactions of AlphaFold progressed from being able to accurately predict individual protein structures to modeling how proteins interact with other molecules like DNA and drugs. These leaps made it far more useful for drug discovery, helping researchers design medicines faster and more precisely, turning the tool into a launchpad for a much larger ambition. 'This was the inspiration for Isomorphic Labs,' Murdoch said of AlphaFold. 'It really demonstrates that we could do something very foundational in AI that could help unlock drug discovery.' In 2024, the same year it released AlphaFold 3, Isomorphic signed major research collaborations with pharma companies Novartis and Eli Lilly. A year later, in April 2025, Isomorphic Labs raised $600 million in its first-ever external funding round, led by Thrive Capital. The deals are part of Isomorphic's plan to build a 'world-class drug design engine,' a system that combines machine learning researchers with pharma veterans to design new medicines faster, more cheaply, and with a higher chance of success. As part of the deals with major pharma players, Isomorphic supports existing drug programs, but it also designs its own internal drug candidates in areas such as oncology and immunology, with the aim of eventually licensing them out after early-stage trials. 'We identify an unmet need, and we start our own drug design programs. We develop those, put them into human clinical trials… we haven't got that yet, but we're making good progress,' he said. Today, pharma companies often spend millions attempting to bring a single drug to market, sometimes with just a 10% chance of success once trials begin. Murdoch believes Isomorphic's tech could radically improve those odds. 'We're trying to do all these things: speed them up, reduce the cost, but also really improve the chance that we can be successful,' he says. He wants to harness AlphaFold's technology to get to a point where researchers have 100% conviction that the drugs they are developing are going to work in human trials. 'One day we hope to be able to say — well, here's a disease, and then click a button and out pops the design for a drug to address that disease,' Murdoch said. 'All powered by these amazing AI tools.' This story was originally featured on
Yahoo
6 hours ago
- Yahoo
Potentially Toxic Chemicals Are Reaching Toddlers Before Kindergarten, Study Finds
Young children nationwide are exposed to a large swath of possibly toxic chemicals before kindergarten, new research suggests 'Our study shows that childhood exposure to potentially harmful chemicals is widespread. This is alarming because we know early childhood is a critical window for brain and body development,' said the study's lead author, Deborah Bennett Researchers found that of the 111 chemicals they focused on, 48 were found in more than 50% of the childrenBefore ever stepping foot inside a kindergarten classroom, young children nationwide are already exposed to a large swath of possibly toxic chemicals, new research suggests. The study, published in Environmental Science and Technology on Monday, June 30, analyzed chemical exposure in 201 kids from the ages of 2-4 years old between 2010 and 2021, using urine samples from the children and most of their mothers during pregnancy. Researchers focused on 111 chemicals. 'Our study shows that childhood exposure to potentially harmful chemicals is widespread. This is alarming because we know early childhood is a critical window for brain and body development,' said the study's lead author, Deborah Bennett in a statement from UC Davis, where she is a professor. 'Many of these chemicals are known or suspected to interfere with hormones, brain development and immune function,' Bennett added. Researchers found that of the 111 chemicals, 96 were detected in at least five kids and 48 were found in more than 50% of the children. In addition, 34 were found in more than 90% of the kids — including nine substances "which have not been included in U.S. national biomonitoring." "This study reveals frequent exposure to multiple chemicals in young U.S. children, often exceeding prenatal levels," the authors wrote in a summary. "Expanded biomonitoring of emerging chemicals of concern and studies of their health effects in this vulnerable population are warranted." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. According to UC Davis, the study found children were exposed to phthalates, parabens, bactericides, and various other chemicals through "everyday activities, such as eating, drinking, breathing indoor and outdoor air and touching contaminated surfaces." 'Exposure to certain chemicals in early childhood, such as pesticides, plasticizers and flame retardants, has been linked to developmental delays, hormone disruption and other long-term health issues,' the study's first author, Jiwon Oh, told UC Davis. Read the original article on People
Yahoo
8 hours ago
- Yahoo
Neanderthals extracted animal fat in advanced food prep 'fat factories' 125,000 years ago: report
Neanderthals living 125,000 years ago in what is now modern-day Germany may have extracted and eaten fat from animal bones through an organized food preparation process that scientists describe as a "fat factory." While excavating the site of a former lake landscape called Neumark-Nord, archaeologists discovered thousands of bones from at least 172 large mammals, along with flint artifacts. The bones, which date back to an interglacial period in which Neanderthals lived, were from animals like red deer and horses, according to a study published on July 2 in Science Advances. While many of the bones that contained less bone marrow were spread out across the archaeological site, researchers observed that many of the marrow-rich bones were located in clusters — sites they call "fat factories." Rare Christian Cross Among Spectacular 1,000-Year-old Viking Treasures Found By Metal Detectorists Researchers believe our extinct ancestors used tools to smash the bones into small fragments and then boiled them for hours. The grease, which then floated to the surface of the water, could be skimmed off the top and eaten — providing a calorie-dense food source for the archaic people. Viking-era Burial Site With Elite Family Treasures And Gifts Discovered, Plus An 'Unusual Casket' Read On The Fox News App Prior to this, evidence of the practice had only dated back to 28,000 years ago, according to the research. "Neanderthals were clearly managing resources with precision — planning hunts, transporting carcasses, and rendering fat in a task-specific area," Dr. Lutz Kindler, the study's first author, said. "They understood both the nutritional value of fat and how to access it efficiently — most likely involving caching carcass parts at places in the landscape for later transport to and use at the grease rendering site. Mysterious 'Dumped' Bodies Of Woman And Child Found By Archaeologists In Picturesque Town Fat was a "life-sustaining" resource for Neanderthals, especially during the winter and spring seasons when carbohydrates were scarce. Their diets consisted largely of animal protein, and consuming lots of protein without other nutrients could lead to a sometimes deadly condition called protein poisoning, the research noted. "The sheer size and extraordinary preservation of the Neumark-Nord site complex gives us a unique chance to study how Neanderthals impacted their environment, both animal and plant life," Dr. Fulco Scherjon, data manager and computer scientist on the project, said. "That's incredibly rare for a site this old—and it opens exciting new possibilities for future research." In recent years, scientists have also discovered that Neanderthals went diving for seashells that they could chip with stone hammers into thin and sharp cutting edges. Similarly, another study suggested Neanderthals may have buried their dead with flowers. Researchers Lutz Kindler and Wil Roebroeks did not immediately respond to Fox News Digital's request for article source: Neanderthals extracted animal fat in advanced food prep 'fat factories' 125,000 years ago: report
